Published in Leukemia on December 01, 1991
Control of cell cycle transcription during G1 and S phases. Nat Rev Mol Cell Biol (2013) 2.17
CNT1 expression influences proliferation and chemosensitivity in drug-resistant pancreatic cancer cells. Cancer Res (2011) 1.06
Nutrition of Streptococcus bovis. J Bacteriol (1948) 5.77
Transport of vitamin B12 in Escherichia coli: common receptor sites for vitamin B12 and the E colicins on the outer membrane of the cell envelope. J Bacteriol (1973) 4.91
A Study of Streptococci Associated with Subacute Bacterial Endocarditis. J Bacteriol (1946) 4.83
Oxidation of Butyric Acid by Streptococci. J Bacteriol (1945) 4.28
The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer. J Clin Oncol (1991) 3.36
Synthesis of a Polysaccharide from Sucrose by Streptococcus S.B.E. J Bacteriol (1946) 3.29
THE ROLE OF THE BACILLUS WELCHII IN ACUTE INTESTINAL OBSTRUCTION: WITH LIGATION OF THE VEINS TO THE OBSTRUCTED LOOP. Ann Surg (1929) 3.18
LYMPH PRESSURES IN STERILE INFLAMMATION. J Exp Med (1932) 3.05
Noxious conditioning as a treatment for rumination. Ment Retard (1967) 3.05
Erythropoiesis with Particular Reference to its Study by Biopsy of Human Bone Marrow: A Review. J Clin Pathol (1949) 2.81
Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney Int (2008) 2.74
Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab (2001) 2.49
Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant (1997) 2.39
Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med (1998) 2.34
Sudden and cardiac death rates in hemodialysis patients. Kidney Int (1999) 2.27
Rapid intravenous infusion of amphotericin B: a pilot study. Am J Med (1992) 2.18
A table for the estimation of the spontaneous mutation rate of cells in culture. Mutat Res (1973) 2.13
Clinical trials of an intravenous oxygenator in patients with adult respiratory distress syndrome. Anesthesiology (1992) 2.11
Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab (2004) 2.07
Transport of vitamin B 12 in Escherichia coli. Location and properties of the initial B 12 -binding site. J Biol Chem (1973) 2.04
Streptococcus S.B.E.: Immunological Characteristics. J Bacteriol (1946) 1.92
Clinical biochemistry. Annu Rev Biochem (1971) 1.92
Who should practise? Where? CMAJ (1994) 1.91
Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association. N Engl J Med (1991) 1.89
NEUROGENIC DISTURBANCES OF THE COLON AND THEIR INVESTIGATION BY THE COLONMETROGRAM: A PRELIMINARY REPORT. Ann Surg (1940) 1.86
Farmworker reports of pesticide safety and sanitation in the work environment. Am J Ind Med (2001) 1.76
A randomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses. The RADIUS Study Group. Am J Obstet Gynecol (1994) 1.76
Bronchoscopy training: current fellows' experiences and some concerns for the future. Chest (2000) 1.75
Apocrine gland carcinoma of the axilla: review of the literature and recommendations for treatment. Am J Clin Oncol (1999) 1.74
Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy. J Clin Oncol (2003) 1.68
Audit of diagnosis of gonorrhoea at first visit to a London genitourinary medicine clinic. Genitourin Med (1994) 1.67
CHANGES IN BRAIN VOLUME AND BLOOD CONTENT AFTER EXPERIMENTAL CONCUSSION. Ann Surg (1943) 1.59
Recompression treatments during the recovery of TWA Flight 800. Undersea Hyperb Med (1997) 1.49
Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. Eur J Cancer (2003) 1.48
S-phase fraction is not correlated with nucleoside transport in acute myeloid leukemia cells. Leukemia (1991) 1.40
Acute nonlymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases. Cancer (1977) 1.35
Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem (1978) 1.35
Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol (2001) 1.31
Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response. Support Care Cancer (2006) 1.30
BLOOD LOSS IN NEUROSURGICAL OPERATIONS. Ann Surg (1938) 1.29
Evaluation of L-asparagine metabolism in animals and man. Cancer Res (1970) 1.29
Quality of life and psychological distress of bone marrow transplant recipients: the 'time trajectory' to recovery over the first year. Bone Marrow Transplant (1998) 1.27
Thermal resistance of salmonellae and staphylococci in foods. Appl Microbiol (1966) 1.27
Vasculas complications in nephrotic syndrome: relationship to steroid therapy and accelerated thromboplastin generation. Br Med J (1970) 1.26
Photostability studies of phycobiliprotein fluorescent labels. Anal Biochem (1987) 1.23
L-asparaginase: clinical, biochemical, pharmacological, and immunological studies. Ann Intern Med (1971) 1.21
Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. Kidney Int (1996) 1.20
Wellbeing of gay, lesbian, and bisexual doctors. BMJ (2001) 1.20
Posterior rhizotomy: a possible substitute for cordotomy in otherwise intractable neuralgias of the trunk and extremities of nonmalignant origin. Clin Neurosurg (1965) 1.20
Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab (1998) 1.18
Prospective trial for the treatment of malignant peritoneal mesothelioma. Am Surg (2001) 1.18
Cordotomy: assessment of its effectiveness and suggestions for its improvement. Clin Neurosurg (1965) 1.15
Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue". Cancer Res (1970) 1.15
Ethnic variation in the correlation between random serum glucose concentration and glycated haemoglobin. Diabet Med (2009) 1.14
Role of social class in excess black stroke mortality. Stroke (1995) 1.13
Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg (2000) 1.11
Familial periodic nystagmus, vertigo, and ataxia. Arch Neurol (1969) 1.11
Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays. Cancer Res (1992) 1.11
Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind phase III trial in patients undergoing open abdominal surgery. Br J Anaesth (2007) 1.09
Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B study. Cancer Chemother Pharmacol (1995) 1.02
Utilization of sorbed compounds by microorganisms specifically isolated for that purpose. Appl Microbiol Biotechnol (1998) 1.02
Mechanism of action of methotrexate. IV. Free intracellular methotrexate required to suppress dihydrofolate reduction to tetrahydrofolate by Ehrlich ascites tumor cells in vitro. Mol Pharmacol (1976) 1.02
Disordered calcium homeostasis of sepsis: association with calcitonin precursors. Eur J Clin Invest (2000) 1.02
Ileal perforation caused by cytomegalovirus infection in a critically ill adult. J Clin Gastroenterol (2000) 1.01
Calcitonin precursors: early markers of gut barrier dysfunction in patients with acute pancreatitis. Pancreas (2003) 1.01
Novel antagonists of the 5-HT3 receptor. Synthesis and structure-activity relationships of (2-alkoxybenzoyl)ureas. J Med Chem (1992) 1.01
The role of chemotherapy in the management of cancer of the head and neck: a review. Cancer (1975) 1.00
Late immunoneutralization of procalcitonin arrests the progression of lethal porcine sepsis. Surg Infect (Larchmt) (2001) 1.00
Effects of anti-inflammatory agents on serum levels of calcitonin precursors during human experimental endotoxemia. J Infect Dis (2001) 1.00
Calcitonin precursors in the prediction of severity of acute pancreatitis on the day of admission. Br J Surg (2003) 0.99
The mechanism of action of methotrexate. III. Requirement of free intracellular methotrexate for maximal suppression of (14C)formate incorporation into nucleic acids and protein. Mol Pharmacol (1975) 0.99
L-asparaginase induced alteration of amethopterin (methotrexate) activity in mouse leukemia L5178Y. Ann N Y Acad Sci (1971) 0.99
Procalcitonin and proinflammatory cytokine interactions in sepsis. Shock (2000) 0.98
Birth cohort evidence of population influences on blood pressure in the United States, 1887-1994. Ann Epidemiol (2001) 0.98
Renal failure secondary to leukemic infiltration of the kidneys. Am J Med (1977) 0.98
Periodic EEG activity in subcortical arteriosclerotic encephalopathy (Binswanger's type). Arch Neurol (1979) 0.97
WATER BALANCE IN NEUROSURGICAL PATIENTS. Ann Surg (1938) 0.97
Primary Closure of Bedsores by Plastic Surgery. Ann Surg (1946) 0.97
Alteration of the pharmacokinetics of high-dose ara-C by its metabolite, high ara-U in patients with acute leukemia. J Clin Oncol (1983) 0.96
Methotrexate cytotoxicity for L5178Y/Asn- lymphoblasts: relationship of dose and duration of exposure to tumor cell viability. Cancer Res (1982) 0.95
Quantitative structure-activity analyses of nitrobenzene toxicity to Tetrahymena pyriformis. Chem Res Toxicol (1998) 0.95
Predictors of success after embryo transfer: experience from a single provider. Am J Obstet Gynecol (2000) 0.94
Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase. Blood (1984) 0.94
Effects of granulocyte colony stimulating factor in a nonneutropenic rodent model of Escherichia coli peritonitis. J Surg Res (1996) 0.92
Impairment of antibacterial defense mechanisms of the lung by extrapulmonary infection. J Infect Dis (1986) 0.92
Reversal of methotrexate binding to dihydrofolate reductase by dihydrofolate. Studies with pure enzyme and computer modeling using network thermodynamics. J Biol Chem (1979) 0.91
Transport, binding, and polyglutamation of methotrexate in freshly isolated rat hepatocytes. Cancer Res (1980) 0.90
Studies on thalassaemia-like anaemias in pregnant immigrants in London. Br J Haematol (1966) 0.90
Effects of 6 months of moderate aerobic exercise training on immune function in the elderly. Mech Ageing Dev (1999) 0.89
Cytokeratin provides a specific marker for human arachnoid cells grown in vitro. Exp Cell Res (1983) 0.89
Treatment and prevention of malignant ascites associated with disseminated intraperitoneal malignancies by aggressive combined-modality therapy. Am Surg (1997) 0.89